Psychemedics Corporation is a diagnostics & research business based in the US. Psychemedics Corporation shares (PMD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.32 – an increase of 0.43% over the previous week. Psychemedics Corporation employs 116 staff and has a trailing 12-month revenue of around $20.8 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.32 |
|---|---|
| 52-week range | $1.63 - $3.93 |
| 50-day moving average | $2.25 |
| 200-day moving average | $2.63 |
| Wall St. target price | $32.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.79 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.314 from 2024-10-15
| 1 week (2024-10-10) | 0.17% |
|---|---|
| 1 month (2024-09-17) | -0.26% |
| 3 months (2024-07-17) | -3.98% |
| 6 months (2024-04-17) | -8.90% |
| 1 year (2023-10-17) | -19.37% |
|---|---|
| 2 years (2022-10-17) | -64.40% |
| 3 years (2021-10-15) | 8.36 |
| 5 years (2019-10-17) | 9.1196 |
| Revenue TTM | $20.8 million |
|---|---|
| Gross profit TTM | $9.3 million |
| Return on assets TTM | -16.24% |
| Return on equity TTM | -61.33% |
| Profit margin | -21.93% |
| Book value | $0.99 |
| Market Capitalization | $13.5 million |
TTM: trailing 12 months
We're not expecting Psychemedics Corporation to pay a dividend over the next 12 months.
Psychemedics Corporation's shares were split on a 1:4 basis on 31 July 2002. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Psychemedics Corporation shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Psychemedics Corporation shares which in turn could have impacted Psychemedics Corporation's share price.
Over the last 12 months, Psychemedics Corporation's shares have ranged in value from as little as $1.63 up to $3.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Psychemedics Corporation's is 0.682. This would suggest that Psychemedics Corporation's shares are less volatile than average (for this exchange).
Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas. .
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.